Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

New agent for atopic dermatitis is endowed with antihistaminic and antiinflammatory effects

Dec. 13, 2000

Berlex now marketing Levulan Kerastick photodynamic therapy in U.S.

Dec. 13, 2000

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

NicOx's HCT-1026 shows promise for treatment of skin inflammation

Nov. 29, 2000

Dusa moves Levulan into phase I/II for the treatment of acne

Nov. 29, 2000

Phytopharm begins phase II trial of P-45 for alopecia areata

Nov. 28, 2000

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Nov. 27, 2000

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Nov. 20, 2000

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

Cellegy seeks approval of Rectogesic in New Zealand

Nov. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...